Fulgent Genetics Shares Outstanding 2015-2025 | FLGT
Fulgent Genetics shares outstanding from 2015 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Fulgent Genetics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 30 |
| 2023 | 30 |
| 2022 | 31 |
| 2021 | 31 |
| 2020 | 24 |
| 2019 | 19 |
| 2018 | 18 |
| 2017 | 18 |
| 2016 | 14 |
| 2015 | 12 |
| 2014 | 0 |
| Fulgent Genetics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 31 |
| 2024-12-31 | 30 |
| 2024-09-30 | 30 |
| 2024-06-30 | 30 |
| 2024-03-31 | 30 |
| 2023-12-31 | 30 |
| 2023-09-30 | 30 |
| 2023-06-30 | 30 |
| 2023-03-31 | 30 |
| 2022-12-31 | 31 |
| 2022-09-30 | 31 |
| 2022-06-30 | 31 |
| 2022-03-31 | 31 |
| 2021-12-31 | 31 |
| 2021-09-30 | 31 |
| 2021-06-30 | 31 |
| 2021-03-31 | 31 |
| 2020-12-31 | 24 |
| 2020-09-30 | 24 |
| 2020-06-30 | 23 |
| 2020-03-31 | 22 |
| 2019-12-31 | 19 |
| 2019-09-30 | 19 |
| 2019-06-30 | 19 |
| 2019-03-31 | 18 |
| 2018-12-31 | 18 |
| 2018-09-30 | 18 |
| 2018-06-30 | 18 |
| 2018-03-31 | 18 |
| 2017-12-31 | 18 |
| 2017-09-30 | 18 |
| 2017-06-30 | 18 |
| 2017-03-31 | 18 |
| 2016-12-31 | 14 |
| 2016-09-30 | 13 |
| 2016-06-30 | 12 |
| 2016-03-31 | 12 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.626B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
| Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
| Tempus AI (TEM) | United States | $9.210B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
| Privia Health (PRVA) | United States | $2.813B | 192.25 |
| Enovis (ENOV) | United States | $1.861B | 10.37 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.579B | 0.00 |
| Phreesia (PHR) | United States | $1.385B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 24.27 |
| Azenta (AZTA) | United States | $1.241B | 57.66 |
| 10x Genomics (TXG) | United States | $1.091B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Talkspace (TALK) | United States | $0.495B | 148.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.438B | 0.00 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.33 |
| Outset Medical (OM) | United States | $0.346B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |